Article Text

PDF
▼Meropenem - an advantageous antibiotic?

Abstract

Meropenem (Meronem - Zeneca) follows imipenem1 as the second carbapenem β-lactam antibiotic to be marketed in the UK. Does meropenem offer therapeutic advantages, particularly when compared with imipenem?

Statistics from Altmetric.com

  • Relevant BNF section: 5.1.2

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.